- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04393272
Digital Intelligent Assistant for Nursing Application (DIANA)
August 24, 2022 updated by: Thomas Munzer, MD, PhD, Geriatrische Klinik St. Gallen
Digital Intelligent Assistant for Nursing Application Evaluation of 3-Dimensional Sensor Technology in Long Term Care and Acute Geriatrics. A Single Center Observational Study
This is an observational study that intends to compare falls or fall-risk related alarms derived from a three-dimensional sensor system with the clinical reality definded by attending nurses.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Three dimensional sensor technology (3DS) is available for fall detection and fall prevention (e.g.
unwanted getting up in persons with risks for frequent falls) in several institutions in Europe and Switzerland.
3DS are capable to analyze completely anonymized data and alert nurses towards a dangerous (fall) or potentially dangerous (getting out of bed) event during day- and nighttime.
Multi-sensor technology has been applied to assess activities of daily living in persons cognitive problems living at home.
To our knowledge, 3DS technology has not been examined as part of a structured clinical protocol.
In addition, the combination of two digital technologies (3DS and a server based software) as an integrative platform could help to develop algorithms to analyze complex human activities such as using a toilet.
Automated analyses of such complex activities have the potential to support nursing staff in the future.
Study Type
Observational
Enrollment (Anticipated)
25
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Thomas Münzer, MD
- Phone Number: +41712438880
- Email: thomas.muenzer@geriatrie-sg.ch
Study Locations
-
-
SG
-
Sankt Gallen, SG, Switzerland, 9000
- Recruiting
- Geriatrische Klinik
-
Contact:
- Thomas Münzer, MD
- Phone Number: +41712438880
- Email: thomas.muenzer@geriatrie-sg.ch
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
75 years and older (OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Due to the observationa design, we will have no control group.
All persons admitted to the rooms equipped with this novel technology are asked to participate.
Description
Inclusion criteria Informed consent given by person or caregiver Patients admitted
- with or without cognitive decline for any reason
- with acute and/or chronic conditions
- after any kind of surgery
Exclusion Criteria:
For Falls assessment by 3D sensors:
• Based on the multifactorial risk for falls there are no exclusion criteria for falls assessment
For the development of toileting algorithm:
- severe urine or fecal incontinence
- permanent indwelling urinary catheter
- permanent urinary or bowel stoma
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Falls detection rate
Time Frame: Through study completion, an average of 6 months
|
Number of falls detected by the system compared to falls detected by nursing staff members
|
Through study completion, an average of 6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment of toileting
Time Frame: Through study completion, an average of 6 months
|
3d sensor system data will be used to develop an algorithm for a complex activity such as using a toilet.
The senors results will be compared with a Nurse led 12 step observation protocol.
Parts of the activity model include: (1) enter the room, (2) go to the toilet, (3) take off clothes, (4) sit on the toilet, (5) clean oneself, (6) stand up, (7) get dressed, (8) flush the toilet, (9) go to the sink, (10) wash hands, (11) dry hands, (12) leave the room, as well as emergencies.
|
Through study completion, an average of 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
May 1, 2021
Primary Completion (ANTICIPATED)
April 30, 2023
Study Completion (ANTICIPATED)
July 31, 2023
Study Registration Dates
First Submitted
May 11, 2020
First Submitted That Met QC Criteria
May 13, 2020
First Posted (ACTUAL)
May 19, 2020
Study Record Updates
Last Update Posted (ACTUAL)
August 25, 2022
Last Update Submitted That Met QC Criteria
August 24, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Behavioral Symptoms
- Mental Disorders
- Digestive System Diseases
- Pathologic Processes
- Urologic Diseases
- Lower Urinary Tract Symptoms
- Urological Manifestations
- Gastrointestinal Diseases
- Urination Disorders
- Intestinal Diseases
- Rectal Diseases
- Elimination Disorders
- Urinary Incontinence
- Frailty
- Enuresis
- Fecal Incontinence
Other Study ID Numbers
- BASEC 20-00904
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
Benjamin Rose Institute on AgingNational Institute on Aging (NIA)RecruitingMild Dementia | Moderate DementiaUnited States
-
Yaolin PeiNational Institutes of Health (NIH)RecruitingEnd of Life Decision Making | Dementia Caregivers | Advanced DementiaUnited States
-
Benuvia Therapeutics Inc.MandaraNot yet recruiting
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityCompletedDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeActive, not recruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
Temple UniversityCompletedDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
NYU Langone HealthRecruiting
-
The University of Hong KongNot yet recruiting
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
Clinical Trials on Three dimensional sensor system designed for fall detection (Fearless)
-
General Hospital of Ningxia Medical UniversityCompletedDevelopmental Dysplasia of the HipChina
-
Universitat Internacional de CatalunyaEnrolling by invitationMigraine | Primary Headache Disorders | Tension-type Headache | Tension Headache | Chronic Overlapping Pain DisordersSpain
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLocalized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Ganglioneuroblastoma | Stage 4 NeuroblastomaUnited States